3188 results for «597»
3188 results
Tips and tricks in valvular intervention
19 Feb 2023 – From PCR Tokyo Valves 2023
In this session, unlock advanced valvular intervention insights (in Japanese). Overcome challenges like aortic valve alignment failure, cardiogenic shock with LMTD and AS and unforseen low atrial septal puncture for successful, optimised procedures.
Selection of the 2023 best clinical cases
19 Feb 2023 – From PCR Tokyo Valves 2023
Explore the most outstanding clinical cases from PCR Tokyo Valves 2023, including a delayed left ventricular rupture after transcatheter edge-to-edge mitral valve repair and successful bailouts in transcatheter mitral valve repair.
PFO closure
17 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session to learn procedural tips and tricks and explore the role of PFO treatment for stroke prevention. Discover the evidence for PFO closure, when it should be considered, pre, intra and post procederal management, and common procedural complications.
Technical challenges and optimal device choice for complex TAVI procedures
18 Feb 2023 – From PCR Tokyo Valves 2023
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Uncover challenges in TAVI for failed bioprostheses and bicuspid aortic valves, emphasising optimal device selection and exploring the latest evolutions in TAVI such as the Medtronic.
Bicuspid valves - Imaging, sizing and technical considerations for success
18 Feb 2023 – From PCR Tokyo Valves 2023
Watch this session to learn more about bicuspid aortic valves: understand the anatomical considerations that define patient selection, explore contemporary sizing strategies and participate in case-based discussions that highlight treatment strategies for bicuspid aortic stenosis.
Predictability and control: Evolut procedural approaches
18 Feb 2023 – From PCR Tokyo Valves 2023
In this session, delve into Evolut procedural approaches. You will be examining the cusp overlap technique, its latest clinical data and outcomes of the Medtronic's newest generational technology: Evolut FX.
Factors to consider during lifetime planning for TAVI patients
19 Feb 2023 – From PCR Tokyo Valves 2023
In this session, explore factors influencing lifetime prognosis and complication avoidance strategies in TAVI patients, focusing on pacemaker and paravalvular leak risk factors.
Left main - DK crush stenting: LIVE case from National University Heart Centre - Singapore
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 3
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 7
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 6
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
Outcome of women in different cardiovascular interventions
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
AICT-AsiaPCR 2023 Opening Ceremony
21 Sep 2023 – From AICT-AsiaPCR 2023
This opening ceremony of the 2023 edition of the AICT-AsiaPCR congress provides an opportunity for its Directors and co-Directors to present the programme, of course, but also to offer several prestigious awards, to introduce the Asian Pacific Society of Interventional Cardiology (APSIC) and its missions, and...
Percutaneous treatment of pure aortic regurgitation: a new indication
21 Sep 2023 – From AICT-AsiaPCR 2023
Analyse the case of an 83-year-old male patient with history of HT, parkinson's disease and minor stroke, who presented with worsening exertional SOB, LVEF 55-60 %, dilated LV, mild MR, and severe AR, and study the different options to treat aortic regurgitation.
